4//SEC Filing
O'Mahony John Mark 4
Accession 0001104659-21-008997
CIK 0001509745other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 9:56 PM ET
Size
8.3 KB
Accession
0001104659-21-008997
Insider Transaction Report
Form 4
O'Mahony John Mark
Chief Manufacturing Officer
Transactions
- Award
Restricted Stock Units
2021-01-26+50,000→ 50,000 totalExercise: $0.00→ Common Stock (50,000 underlying) - Award
Employee Stock Option (Right to Buy)
2021-01-26+150,000→ 150,000 totalExercise: $2.57Exp: 2031-01-25→ Common Stock (150,000 underlying)
Footnotes (3)
- [F1]The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable in a series of 36 equal monthly installments until the Option is fully vested, with the first such monthly installment vesting on the one month anniversary of January 26, 2021, the Vesting Start Date.
- [F2]The Restricted Stock Units were awarded pursuant to Leap's 2016 Equity Incentive Plan for no consideration. Restricted Stock Units will be settled in common stock.
- [F3]The Restricted Stock Units will cliff vest and be settled after three years of continuous service or upon a change of control of Leap, whichever is earlier.
Documents
Issuer
LEAP THERAPEUTICS, INC.
CIK 0001509745
Entity typeother
Related Parties
1- filerCIK 0001808556
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 9:56 PM ET
- Size
- 8.3 KB